Max Healthcare Institute Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Operating Revenue	81,403	70,285	54,060	45,626	39,366	25,080
Revenue	81,403	70,285	54,060	45,626	39,366	25,080
Revenue Growth (YoY)	24.44%	30.01%	18.49%	15.90%	56.96%	136.82%
Cost of Revenue	30,924	26,511	20,529	17,314	17,481	12,324
Gross Profit	50,480	43,774	33,531	28,312	21,885	12,755
Selling, General & Admin	17,275	14,747	11,169	9,863	8,729	5,657
Other Operating Expenses	11,342	10,157	7,159	5,887	3,365	2,927
Operating Expenses	32,860	28,499	20,778	18,072	14,305	10,325
Operating Income	17,619	15,275	12,753	10,240	7,580	2,431
Interest Expense	-2,074	-1,488	-445.6	-713.2	-900.1	-1,710
Interest & Investment Income	1,106	1,172	1,562	1,124	750.9	767.3
Earnings From Equity Investments	-	-	-	-	-	-230.5
Currency Exchange Gain (Loss)	-7	-7	3	-2.4	-3.4	178.8
Other Non Operating Income (Expenses)	330.7	204.4	41.6	86.7	207.3	67.4
EBT Excluding Unusual Items	16,975	15,158	13,914	10,735	7,634	1,504
Merger & Restructuring Charges	-	-	-	-	-90.3	-377.8
Gain (Loss) on Sale of Assets	1.1	1.1	4.5	13.3	-30.6	-2.4
Asset Writedown	-	-	-	-	-0.6	-81.4
Other Unusual Items	-841.2	-1,095	-265.4	-111.2	-123.8	-1,959
Pretax Income	16,135	14,064	13,653	10,637	7,389	-917
Income Tax Expense	1,943	3,305	3,077	-397.9	1,339	458.5
Earnings From Continuing Operations	14,192	10,759	10,576	11,035	6,051	-1,376
Net Income to Company	14,192	10,759	10,576	11,035	6,051	-1,376
Net Income	14,192	10,759	10,576	11,035	6,051	-1,376
Net Income to Common	14,192	10,759	10,576	11,035	6,051	-1,376
Net Income Growth	40.73%	1.73%	-4.16%	82.38%	-	-
Shares Outstanding (Basic)	972	972	972	970	967	863
Shares Outstanding (Diluted)	977	977	975	972	969	863
Shares Change (YoY)	-0.10%	0.20%	0.39%	0.24%	12.30%	47.77%
EPS (Basic)	14.60	11.07	10.89	11.38	6.25	-1.59
EPS (Diluted)	14.53	11.01	10.84	11.36	6.24	-1.59
EPS Growth	40.94%	1.57%	-4.58%	82.05%	-	-
Free Cash Flow	-	4,938	3,357	9,485	1,872	-5.6
Free Cash Flow Per Share	-	5.05	3.44	9.76	1.93	-0.01
Dividend Per Share	-	1.500	1.500	1.000	-	-
Dividend Growth	-	-	50.00%	-	-	-
Gross Margin	62.01%	62.28%	62.02%	62.05%	55.59%	50.86%
Operating Margin	21.64%	21.73%	23.59%	22.44%	19.25%	9.69%
Profit Margin	17.43%	15.31%	19.56%	24.19%	15.37%	-5.49%
Free Cash Flow Margin	-	7.03%	6.21%	20.79%	4.75%	-0.02%
EBITDA	21,384	18,312	14,819	12,226	9,465	3,896
EBITDA Margin	26.27%	26.05%	27.41%	26.80%	24.04%	15.53%
D&A For EBITDA	3,764	3,037	2,066	1,986	1,886	1,465
EBIT	17,619	15,275	12,753	10,240	7,580	2,431
EBIT Margin	21.64%	21.73%	23.59%	22.44%	19.25%	9.69%
Effective Tax Rate	12.04%	23.50%	22.54%	-	18.12%	-
Revenue as Reported	83,019	71,841	55,830	47,018	40,588	26,194
Advertising Expenses	-	-	-	-	446.2	167.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.